verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: eugia us llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler eugia us llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Eugia US LLC

Identifiers & Regulatory

Product NDC 55150-342
Product ID 55150-342_efd433ac-b10b-48e4-bda2-4d0395062d34
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212965
Listing Expiration 2026-12-31
Marketing Start 2020-07-06

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55150342
Hyphenated Format 55150-342

Supplemental Identifiers

RxCUI
1665057 1665061
UPC
0355150342013 0355150343010 0355150342051
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA212965 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-01) / 2 mL in 1 VIAL, SINGLE-DOSE
  • 5 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-05) / 2 mL in 1 VIAL, SINGLE-DOSE
  • 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-25) / 2 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (3)

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "efd433ac-b10b-48e4-bda2-4d0395062d34", "openfda": {"upc": ["0355150342013", "0355150343010", "0355150342051"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["def3b9ba-523d-4b83-a80d-fa6f362e111c"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-342-01", "marketing_start_date": "20200706"}, {"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-05)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-342-05", "marketing_start_date": "20200706"}, {"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-25)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-342-25", "marketing_start_date": "20200706"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "55150-342_efd433ac-b10b-48e4-bda2-4d0395062d34", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "55150-342", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA212965", "marketing_category": "ANDA", "marketing_start_date": "20200706", "listing_expiration_date": "20261231"}